NL Ontmanteling is eerste stap in Telix Pharmaceuticals’ plan om productie van medische radio-isotopen in Europa op te starten.
NL Ontmanteling is eerste stap in Telix Pharmaceuticals’ plan om productie van medische radio-isotopen in Europa op te starten.
EN Decommissioning the first step in Telix Pharmaceuticals’ plan to commence production of medical radioisotopes in Europe
Tiếng hà lan | tiếng Anh |
---|---|
ontmanteling | decommissioning |
stap | step |
plan | plan |
productie | production |
medische | medical |
europa | europe |
NL Telix Pharmaceuticals, met hoofdzetel in Australië en internationale activiteiten in België, Zwitserland, Japan en de Verenigde Staten, verwierf de site in Seneffe in april 2020
EN Telix Pharmaceuticals, headquartered in Australia with international operations in Belgium, Switzerland, Japan and the United States, acquired the Seneffe site in April 2020
Tiếng hà lan | tiếng Anh |
---|---|
australië | australia |
internationale | international |
activiteiten | operations |
japan | japan |
site | site |
april | april |
NL Sébastien Linard de Guertechin, algemeen directeur van de faciliteit in Seneffe, verklaarde: "Telix is verheugd met SCK CEN samen te werken voor de ontmanteling
EN Sébastien Linard de Guertechin, General Manager of the Seneffe Facility stated, “Telix is delighted to be working with SCK CEN for the decommissioning
Tiếng hà lan | tiếng Anh |
---|---|
algemeen | general |
directeur | manager |
faciliteit | facility |
is | is |
verheugd | delighted |
sck | sck |
werken | working |
ontmanteling | decommissioning |
cen | cen |
NL De site zal naar verwachting dienen als de belangrijkste Europese productievestiging van Telix.
EN The site is expected to serve as Telix’s primary European manufacturing site.
Tiếng hà lan | tiếng Anh |
---|---|
site | site |
europese | european |
belangrijkste | primary |
NL In 2013 verhuisde Karen vervolgens naar Boston om de Research and Development en Corporate Development teams voor Biogen te gaan leiden, voordat ze de CHRO werd bij Alnylam Pharmaceuticals.
EN In 2013, Karen relocated to Boston to lead the Research and Development and Corporate Development teams for Biogen before becoming the CHRO for Alnylam Pharmaceuticals.
Tiếng hà lan | tiếng Anh |
---|---|
research | research |
development | development |
corporate | corporate |
teams | teams |
leiden | lead |
boston | boston |
werd | becoming |
NL In 2013 verhuisde Karen vervolgens naar Boston om de Research and Development en Corporate Development teams voor Biogen te gaan leiden, voordat ze de CHRO werd bij Alnylam Pharmaceuticals.
EN In 2013, Karen relocated to Boston to lead the Research and Development and Corporate Development teams for Biogen before becoming the CHRO for Alnylam Pharmaceuticals.
Tiếng hà lan | tiếng Anh |
---|---|
research | research |
development | development |
corporate | corporate |
teams | teams |
leiden | lead |
boston | boston |
werd | becoming |
Hiển thị 6 trong số 6 bản dịch